Pharma’s Next Billion Patients: Taking Innovation to New Markets

Pharma companies are facing growing pressure to expand access to therapies across diverse healthcare markets while balancing affordability, commercial growth, and local healthcare realities. As demand rises in emerging and underserved regions, companies are rethinking how therapies are launched, distributed, and supported beyond traditional Western markets.

At the same time, digital health infrastructure, mobile-first care models, and new partnership approaches are creating opportunities to reach patients in different ways. Success increasingly depends on understanding local care pathways, reimbursement environments, regulatory expectations, and cultural differences across regions.

This roundtable brings together leaders across pharma, digital health, market access, and healthcare delivery to explore how organizations are adapting commercial and access strategies for global growth. The discussion will focus on what it takes to scale innovation internationally while maintaining quality, sustainable business models, and meaningful patient impact.

Join us to discuss:

• How are pharma companies adapting commercial and access models across different global markets?

• What role are digital health, mobile platforms, and local partnerships playing in expanding access to care?

• What challenges emerge when scaling therapies internationally across different reimbursement systems, regulatory environments, and patient populations?